Large Cell Lung Carcinoma Recruiting Phase 3 Trials for Nivolumab (DB09035)

Also known as: Carcinoma, Large Cell Lung

IndicationStatusPhase
DBCOND0044133 (Large Cell Lung Carcinoma)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02194738Genetic Testing in Screening Patients With Stage IB-IIIA Non-Small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)Screening